Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2005
05/05/2005US20050095681 Intracellular modulators of apoptopic cell death pathways
05/05/2005US20050095663 Via 6-(4-chlorophenyl)-2-(2'-pentyn-4'-ene-1-yl)-3(2H)-pyridazinone for inhibition of delta-9 fatty acid desaturase
05/05/2005US20050095584 Method for determining early HCV seroconversion
05/05/2005US20050095260 Antiviral composition
05/05/2005US20050095258 Vaccine inhibiting gonadotropin releasing hormone activity in cattle and protecting against bovine herpes virus type 1; polynucleotides, vectors, transformed cells
05/05/2005US20050095257 Cancer and viral infections vaccines; increased immunogenicity
05/05/2005US20050095230 For treatment of cancer or virus infection (HIV)
05/05/2005US20050095224 Compositions and method for treating hepatitis virus infection
05/04/2005EP1528102A2 Cloning and recombinant productions of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon
05/04/2005EP1528058A1 Polymorphic crystalline forms of celecoxib
05/04/2005EP1528057A1 Nonnucleoside inhibitors of reverse transcriptase for the treatment of HIV infection
05/04/2005EP1527685A2 Synergistic microbicidal combination
05/04/2005EP1527684A2 Synergistic microbicidal combination
05/04/2005EP1527171A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
05/04/2005EP1527159A1 Probiotic propionibacterium jensenii 702
05/04/2005EP1527089A2 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof
05/04/2005EP1527088A1 Pegylated t20 polypeptide
05/04/2005EP1527082A2 Anti-viral 7-deaza d-nucleosides and uses thereof
05/04/2005EP1527080A2 Campylobacter glycans and glycopeptides
05/04/2005EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators
05/04/2005EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
05/04/2005EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
05/04/2005EP1527050A1 Quinoline derivatives and their use as mycobacterial inhibitors
05/04/2005EP1526896A1 Antibacterial ester macrocycles
05/04/2005EP1526863A2 Using heat shock proteins to increase immune response
05/04/2005EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof
05/04/2005EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
05/04/2005EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound
05/04/2005EP1526846A2 Gelatin capsule exhibiting reduced cross-linking
05/04/2005EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage
05/04/2005EP1526844A2 Pellicle-resistant gelatin capsule
05/04/2005EP1526843A1 Method of preparing solid dosage forms coated in two layers comprising a water-insoluble polymer and a water-soluble pore former
05/04/2005EP1414835B1 9a-n-[n'-(phenylsulfonyl)carbamoyl] derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerythromycin a and of 5-o-desosaminyl-9-deoxo-9-dihydro-9a-aza-9a-homoerythronolide a
05/04/2005EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
05/04/2005EP1341539B1 Anti-inflammatory agents
05/04/2005EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors
05/04/2005EP1272500B1 Process for preparing 6-o-alkenyl-subsituted erythromycin derivatives
05/04/2005EP1232148B1 Use of benzotriazole uv absorbers
05/04/2005EP1225895B1 Fab i inhibitors
05/04/2005EP1156782B1 Echinocandin pharmaceutical formulations containing micelle-forming surfactants
05/04/2005EP1127057B1 Naphthyridine compounds and thier azaisosteric analogues as antibacterials
05/04/2005EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/04/2005EP1119567B1 Quinazoline derivatives
05/04/2005EP1109812B1 Pyrrolobenzodiazepines
05/04/2005EP0994730B1 LABELLED FACTOR XIIIa SUBSTRATES
05/04/2005EP0946177B1 METHOD OF INHIBITING BIOSYNTHESIS OF EIf5A
05/04/2005EP0835266B1 Modified/chimeric superantigens and their use
05/04/2005EP0781340B1 Vaccine against group A Streptococcal infection
05/04/2005EP0668916B1 Haemophilus outer membrane protein
05/04/2005CN1612942A Viral capsid assembly intermediates
05/04/2005CN1612935A Expression vectors encoding epitopes of target-associated antigens and methods for their design
05/04/2005CN1612888A Macrolides
05/04/2005CN1612879A Novel carbapenem compounds
05/04/2005CN1612878A Synthesis and purification of valacyclovir
05/04/2005CN1612869A Novel 1, 2, 4-thiadiazolium derivatives as melanocortin receptor modulators
05/04/2005CN1612864A Novel alkansulfonamides as endothelin antagonists
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1612763A Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
05/04/2005CN1612753A Mycobacterial vaccine
05/04/2005CN1612749A Mycoplasma hyopneumoniae vaccine and methods for reducing mycoplasma bovis pneumonia in cattle
05/04/2005CN1612743A Herbal composition phy906 and its use in chemotheraphy
05/04/2005CN1612735A Uses for anti-malarial therapeutic agents
05/04/2005CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases
05/04/2005CN1612688A Anti-pathogenic composition useful in blood preservation
05/04/2005CN1611604A Swine alpha-interferon gene synthesis, expression vector establishment and product preparing method
05/04/2005CN1611497A Anti-AIDS virus active substance desmosdumotin D and desmosdumotin and its analogue
05/04/2005CN1611263A Foot-mouth disease vaccine tag
05/04/2005CN1611260A Combined medicine of adefovir dipivoxil
05/04/2005CN1611258A Medicinal composition for treating exogenous febrile disease
05/04/2005CN1611240A Fresh ginger soft capsule and its preparing method
05/04/2005CN1611236A Chinese medicine composition for treating hepatitis and its preparing method
05/04/2005CN1611221A Injection liquid containing alprostadic and its production process
05/04/2005CN1611218A Fixed dose compound preparation of antitubercular drug and its preparing method
05/04/2005CN1611217A Antimicrobial medicinal composition and its production process
05/04/2005CN1611216A Anti-fungus external-use agent for finger nail
05/04/2005CN1611213A Novel 13 uses of neoarsphenamine
05/04/2005CN1200000C Cyclie somatostatin analogs
05/04/2005CN1199946C Specific indole compound and its preparation and use in treating and preventing cancers
05/04/2005CN1199685C Medicine for treating upper respiratory tract infection type cold
05/04/2005CN1199684C Chinese medicine for treating hepatitis B and process for preparing same
05/04/2005CN1199676C Veterinary Chinese medicine injection liquid for cleaning heat, diminishing inflammation, antibacterial and anti virus
05/04/2005CN1199649C Use of New Zealand vitexin-1 in preparation of antiviral drug
05/04/2005CN1199645C Application of N-acetyl-D-aminoglucose in the preparation of medicine for treating urogenital system infection
05/04/2005CN1199639C Medicine for curing subacute tyroiditis
05/03/2005US6888033 Contacting picornavirus with 2,6-dihydroxy acetophenone or its salt to inhibit replication of picornavirus
05/03/2005US6887996 Compounds and their use
05/03/2005US6887994 C-nitroso compounds and use thereof
05/03/2005US6887989 Sequences from Piscirickettsia salmonis
05/03/2005US6887981 Natural antibacterial peptide, the nucleotide sequence encoding it and the use thereof
05/03/2005US6887976 Improved mammalian safety profile; glycopeptide phosphonate derivatives of invention unexpectedly exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammal; antibacterial agents
05/03/2005US6887906 Compositions and methods for the delivery of oligonucleotides via the alimentary canal
05/03/2005US6887895 Aminolyzing; alcoholysis; comprises acid catalysts; for treatment of tumors or inhibition of fungi
05/03/2005US6887894 Use of lipoic acid for improving the bioavailability of mineral salts
05/03/2005US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them
05/03/2005US6887879 Pharmaceutical combination of antiviral agents
05/03/2005US6887877 Viricide for hepatitis virus
05/03/2005US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same
05/03/2005US6887869 Mikanolide derivatives, their preparation and therapeutic uses
05/03/2005US6887861 Drug delivery
1 ... 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 991 992 993 ... 1798